GLP-1 agonists are a class of medications originally developed to treat type 2 diabetes, but their benefits extend well beyond glycemic control
This makes it one of the most widely studied weight-loss drugs currently in use in the medical field
Understanding how these compounds interact, their safety profile, and personalized dosing can help patients achieve more sustainable results
Semaglutide, including its brand names like Ozempic and Mounjaro, is generally well-tolerated, but like all medications, it can have potential side effects, some of which may indirectly impact a womans menstrual cycle
All GLP-1 receptor agonists affect gut motility to some degree, with important differences in their frequency and severity of digestive side effects